Case-matched study reports perioperative outcomes of acellular dermal matrix in breast reconstruction, highlighting clinical safety concerns.
Acellular dermal matrix (ADM) is commonly used in implant-based breast reconstruction due to improved soft-tissue support and control of the implant pocket and decreased capsular contracture. However, concerns about complications have prompted the FDA to request more clinical data. This large-scale study aims to examine perioperative outcomes of ADM use in breast reconstruction.
No takes yet. Share an insight, caveat, or question.
Kilmer et al. (2024) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: